IRIS Accounts Production v24.3.2.46 14772748 director 1.4.24 31.1.25 31.1.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh147727482024-03-31147727482025-01-31147727482024-04-012025-01-31147727482023-03-30147727482023-03-312024-03-31147727482024-03-3114772748ns15:EnglandWales2024-04-012025-01-3114772748ns14:PoundSterling2024-04-012025-01-3114772748ns10:Director12024-04-012025-01-3114772748ns10:PrivateLimitedCompanyLtd2024-04-012025-01-3114772748ns10:SmallEntities2024-04-012025-01-3114772748ns10:AuditExempt-NoAccountantsReport2024-04-012025-01-3114772748ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-01-3114772748ns10:SmallCompaniesRegimeForAccounts2024-04-012025-01-3114772748ns10:FullAccounts2024-04-012025-01-3114772748ns10:RegisteredOffice2024-04-012025-01-3114772748ns5:CurrentFinancialInstruments2025-01-3114772748ns5:CurrentFinancialInstruments2024-03-3114772748ns5:ShareCapital2025-01-3114772748ns5:ShareCapital2024-03-3114772748ns5:RetainedEarningsAccumulatedLosses2025-01-3114772748ns5:RetainedEarningsAccumulatedLosses2024-03-3114772748ns5:ComputerEquipment2024-04-012025-01-3114772748ns5:ComputerEquipment2024-03-3114772748ns5:ComputerEquipment2025-01-3114772748ns5:ComputerEquipment2024-03-31
REGISTERED NUMBER: 14772748 (England and Wales)









MBN MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 APRIL 2024 TO 31 JANUARY 2025






MBN MEDICAL LIMITED (REGISTERED NUMBER: 14772748)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 APRIL 2024 TO 31 JANUARY 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MBN MEDICAL LIMITED

COMPANY INFORMATION
FOR THE PERIOD 1 APRIL 2024 TO 31 JANUARY 2025







DIRECTOR: Dr M Boctor Nader





REGISTERED OFFICE: Station House
North Street
Havant
Hampshire
PO9 1QU





REGISTERED NUMBER: 14772748 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

MBN MEDICAL LIMITED (REGISTERED NUMBER: 14772748)

BALANCE SHEET
31 JANUARY 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - 899

CURRENT ASSETS
Cash at bank 18,460 33,674

CREDITORS
Amounts falling due within one year 5 15,572 23,807
NET CURRENT ASSETS 2,888 9,867
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,888

10,766

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 2,886 10,764
2,888 10,766

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 January 2025.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 January 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 February 2025 and were signed by:





Dr M Boctor Nader - Director


MBN MEDICAL LIMITED (REGISTERED NUMBER: 14772748)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 APRIL 2024 TO 31 JANUARY 2025

1. STATUTORY INFORMATION

MBN Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Company year end changed
"The financial statements have been prepared for the Shorter period of 10 months and therefore the amounts presented in the financial statements (including the related notes) are not entirely comparable with the previous period of 12 months."The reason for the shorter period of reporting is that the company ceased trading on 31 Jan, 2025"

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 (2024 - 1 ) .

MBN MEDICAL LIMITED (REGISTERED NUMBER: 14772748)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 APRIL 2024 TO 31 JANUARY 2025

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2024 1,349
Disposals (1,349 )
At 31 January 2025 -
DEPRECIATION
At 1 April 2024 450
Eliminated on disposal (450 )
At 31 January 2025 -
NET BOOK VALUE
At 31 January 2025 -
At 31 March 2024 899

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Taxation and social security 13,480 20,420
Other creditors 2,092 3,387
15,572 23,807